Avivagen, Inc - VIV

Avivagen, Inc. develops and commercializes various products to replace antibiotics in livestock feeds to optimize the health and growth of the animals by supporting the animal’s own health defenses. The company offers products based on its OxC-Beta technology, an animal immune system to maintain and enhance health by supporting immune function and usefully reducing excess inflammation. Its products include Vivamune health chews for cats and dogs; Oximunol chewable tablets that support the immune system to optimize overall health and well-being for dogs; and Carotenoid oxidation products to promote and maintain health in companion animals. The company was formerly known as Chemaphor, Inc. and changed its name to Avivagen, Inc. in May 2012. The company is headquartered in Ottawa, Canada.